Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solange Peters

Showing results (301-310 of 362) with videos related to

Pageof 37
Sort By:
Health Science Reports|May 15, 2020
Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger ToolAnne Gerber, André Da Silva Lopes, Natacha Szüts, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 24, 2025
Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS StudySolange Peters, Christian Schulz, Martin Reck, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 2026
Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancerTeodora Radonic, Sepehr Rahmani-Khajouei, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 1, 2021
Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape ProjectStephen P Finn, Alfredo Addeo, Urania Dafni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2025
Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen-Positive Advanced/Metastatic Solid TumorsIgnacio Melero, Josep Tabernero, Neeltje Steeghs, et al.
Journal of Translational Medicine|September 4, 2022
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy)Paolo A Ascierto, Sanjiv S Agarwala, Christian Blank, et al.
Nature Communications|May 12, 2025
Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneityYixing Dong, Chiara Saglietti, Quentin Bayard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2021
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II TrialSacha I Rothschild, Alfred Zippelius, Eric I Eboulet, et al.
Cancer|August 26, 2025
Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024Narjust Florez, Sandip Patel, Heather A Wakelee, et al.
Translational Lung Cancer Research|May 20, 2021
Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinomaDaniel Kazdal, Eugen Rempel, Cristiano Oliveira, et al.
Pageof 37

Showing results (301-310 of 362) with videos related to

Sort By:
Pageof 37
Health Science Reports|May 15, 2020
Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger ToolAnne Gerber, André Da Silva Lopes, Natacha Szüts, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 24, 2025
Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS StudySolange Peters, Christian Schulz, Martin Reck, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 2026
Prevalence and characteristics of NTRK fusions in 25,946 patients with non-small cell lung cancerTeodora Radonic, Sepehr Rahmani-Khajouei, Urania Dafni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 1, 2021
Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape ProjectStephen P Finn, Alfredo Addeo, Urania Dafni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2025
Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen-Positive Advanced/Metastatic Solid TumorsIgnacio Melero, Josep Tabernero, Neeltje Steeghs, et al.
Journal of Translational Medicine|September 4, 2022
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 2nd - 4th, 2021, Italy)Paolo A Ascierto, Sanjiv S Agarwala, Christian Blank, et al.
Nature Communications|May 12, 2025
Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneityYixing Dong, Chiara Saglietti, Quentin Bayard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 12, 2021
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II TrialSacha I Rothschild, Alfred Zippelius, Eric I Eboulet, et al.
Cancer|August 26, 2025
Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024Narjust Florez, Sandip Patel, Heather A Wakelee, et al.
Translational Lung Cancer Research|May 20, 2021
Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinomaDaniel Kazdal, Eugen Rempel, Cristiano Oliveira, et al.
Pageof 37